Applied Clinical Trials
Cancer Research UK (CRUK) followed such advice when it decided to have its Center for Drug Development (CDD) adopt a risk-based monitoring (RBM) approach across its entire portfolio of clinical trials.
Sherraine Hurd
Advertisement
Articles by Sherraine Hurd
Advertisement
Latest Updated Articles
Risking it All? Going All in on RBM AdoptionFebruary 1st 2015
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
3
How to recruit specialty volunteer populations for early-phase clinical research: 5 things to ask when choosing a CRO partner
4